title: Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel.
abstract: The relationship between occupational exposure to antineoplastic drugs and the presence of acute symptoms of exposure was investigated by questionnaire. Data were derived from a questionnaire distributed to 8566 pharmacists, pharmacy technicians, nurses, and nurse aids at 57 member institutions of the National Surgical Adjuvant Breast and Bowel Project nationwide. Of the 4659 respondents (54%), 1057 were pharmacists or pharmacy technicians; after exclusions, the sample size was 738. Data were collected on four handling activities: mixing of antineoplastic drugs, administering these drugs, cleaning up spills, and handling patient excreta. Information on mixing was divided into dose, duration, use of protection, and reported skin contact. Respondents indicated which of 27 acute symptoms they had experienced during the past three months. Handling of antineoplastics was associated with a small but significant increase in the number of symptoms compared with controls; reported skin contact was the most important predictor of symptoms. The number of doses handled and the extent of protection were significantly associated with the number of symptoms, but their effect was not independent of that of skin contact. Body mass was significantly associated with the number of symptoms in women but not men. Pharmacists and technicians who handle antineoplastic drugs reported more symptoms associated with exposure than did those who do not handle such agents. All available protective measures should be used.
authors.affiliation: Kaiser Permanente Center for Health Research, Portland, OR 97215-1098.
authors.forename: B G
authors.initials: BG
authors.lastname: Valanis
authors.forename: W M
authors.initials: WM
authors.lastname: Vollmer
authors.forename: K T
authors.initials: KT
authors.lastname: Labuhn
authors.forename: A G
authors.initials: AG
authors.lastname: Glass
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004339:Drug Compounding; D005260:Female; D006801:Humans; D008297:Male; D008452:Maximum Allowable Concentration; D008875:Middle Aged; D016273:Occupational Exposure / Q000706:statistics & numerical data*; D010564:Personnel, Hospital; D010595:Pharmacists; D010607:Pharmacy Service, Hospital; D011795:Surveys and Questionnaires; D014481:United States / Q000453:epidemiology; D000078329:Workforce
chemical_list: D000970:Antineoplastic Agents